The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis. 't Hart BA, Jagessar AS, Haanstra K, Verschoor E, Laman JD, Kap YS Front Immunol. 2013; 4:145. Epub 2013 Jun 13. PMID: 23781220. Abstract CommentRecommendBookmarkWatch